Gastric bezoar

Also known as: Bezoars / Bezoar / Bezoar (morphologic abnormality) / Bezoar (disorder)

Drug	Drug Name	Drug Description
DB01233	Metoclopramide	An antiemetic agent and dopamine D2 antagonist used in the treatment of gastroesophageal reflux disease, prevention of nausea and vomiting, and to stimulate gastric emptying.

Drug	Drug Name	Target	Type
DB01233	Metoclopramide	Muscarinic acetylcholine receptor M1	target
DB01233	Metoclopramide	Dopamine D2 receptor	target
DB01233	Metoclopramide	Cytochrome P450 2D6	enzyme
DB01233	Metoclopramide	5-hydroxytryptamine receptor 4	target
DB01233	Metoclopramide	5-hydroxytryptamine receptor 3A	target
DB01233	Metoclopramide	Cytochrome P450 3A4	enzyme
DB01233	Metoclopramide	Cytochrome P450 1A2	enzyme
DB01233	Metoclopramide	P-glycoprotein 1	transporter
DB01233	Metoclopramide	Alpha-1-acid glycoprotein 1	carrier

Drug	Drug Name	Phase	Status	Count